We are live on ! Find out more
MBIO icon

Mustang Bio

27 hedge funds and large institutions have $3.94M invested in Mustang Bio in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $3.62M → $3.94M (+$320K)

0.16% more ownership

Funds ownership: 0.01%0.17% (+0.16%)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

44% less funds holding

Funds holding: 4827 (-21)

75% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 28

Holders
27
Holders Change
-21
Holders Change %
-43.75%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
5
Closed
28
Calls
Puts
Net Calls
Net Calls Change

MBIO Hedge Fund Activity: Q2 2023 in Review

27 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2023, worth a combined $3.94M — up 8.8% from $3.62M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of MBIO and 7 opened new positions — a net loss of 21 holders — while 5 trimmed existing stakes and 5 added.

The largest buyer was Koss-Olinger Consulting, opening a new position worth an estimated $502K. The largest seller was Laurion Capital Management, cutting an estimated $228K.

  • 27 institutional investors held Mustang Bio (MBIO) as of Q2 2023, down from 48 in Q1 2023.
  • Funds reported $3.94M of Mustang Bio stock for Q2 2023, up 8.8% quarter-over-quarter.
  • 7 funds opened new Mustang Bio positions in Q2 2023 and 28 closed out, a net change of -21 holders.
  • The largest Mustang Bio buyer in Q2 2023 was Koss-Olinger Consulting, an estimated $502K added.
  • The largest Mustang Bio seller in Q2 2023 was Laurion Capital Management, an estimated $228K sold.

Based on aggregated 13F filings for Q2 2023.